Sellami, M., Meghraoui-Kheddar, A., Terryn, C., Fichel, C., Bouland, N., Diebold, M., Guenounou, M., Hry-Huynh, S., and Le Naour, R
Similarly, SGLT2 inhibitors were not linked with changes in RARI, which semaglutide reduced in both SGLT2 inhibitor users and nonusers ( P -interaction=0.29)
Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulphonylurea: the PIONEER 3 randomized clinical trial
Alcohol may increase the risk of side effects and can interfere with the effectiveness of the medication
Acta Neuropathol (2010) 119(6):75570
Persistence to treatment with novel antidiabetic drugs (dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter-2 inhibitors, and glucagon-like peptide-1 receptor agonists) in people with type 2 diabetes: a nationwide cohort study